J. Nick Riehle, Chief Financial Officer at Chelsea Therapeutics International, Ltd. (CHTP), bought 3,000 shares at $4.83 ($14K) on 2010-11-04, disclosed to the SEC on 2010-11-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CHTP | BUY | 2008-09-25 | $6K | — | Filing → |